Literature DB >> 29462330

Cell surface chondroitin sulphate proteoglycan 4 (CSPG4) binds to the basement membrane heparan sulphate proteoglycan, perlecan, and is involved in cell adhesion.

Fengying Tang1, Megan S Lord1, William B Stallcup2, John M Whitelock1.   

Abstract

Chondroitin sulphate proteoglycan 4 (CSPG4) is a cell surface proteoglycan highly expressed by tumour, perivascular and oligodendrocyte cells and known to be involved cell adhesion and migration. This study showed that CSPG4 was present as a proteoglycan on the cell surface of two melanoma cell lines, MM200 and Me1007, as well as shed into the conditioned medium. CSPG4 from the two melanoma cell lines differed in the amount of chondroitin sulphate (CS) decoration, as well as the way the protein core was fragmented. In contrast, the CSPG4 expressed by a colon carcinoma cell line, WiDr, was predominantly as a protein core on the cell surface lacking glycosaminoglycan (GAG) chains. This study demonstrated that CSPG4 immunopurified from the melanoma cell lines formed a complex with perlecan synthesized by the same cultured cells. Mechanistic studies showed that CSPG4 bound to perlecan via hydrophobic protein-protein interactions involving multiple sites on perlecan including the C-terminal region. Furthermore, this study revealed that CSPG4 interacted with perlecan to support cell adhesion and actin polymerization. Together these data suggest a novel mechanism by which CSPG4 expressing cells might attach to perlecan-rich matrices so as those found in connective tissues and basement membranes.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29462330      PMCID: PMC5905647          DOI: 10.1093/jb/mvy008

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  70 in total

1.  NG2 proteoglycan expression by pericytes in pathological microvasculature.

Authors:  Ugur Ozerdem; Edward Monosov; William B Stallcup
Journal:  Microvasc Res       Date:  2002-01       Impact factor: 3.514

2.  A role for perlecan in the suppression of growth and invasion in fibrosarcoma cells.

Authors:  M Mathiak; C Yenisey; D S Grant; B Sharma; R V Iozzo
Journal:  Cancer Res       Date:  1997-06-01       Impact factor: 12.701

3.  Electrophoretic, biosensor, and bioactivity analyses of perlecans of different cellular origins.

Authors:  S Knox; J Melrose; J Whitelock
Journal:  Proteomics       Date:  2001-12       Impact factor: 3.984

4.  High-affinity binding of basic fibroblast growth factor and platelet-derived growth factor-AA to the core protein of the NG2 proteoglycan.

Authors:  L Goretzki; M A Burg; K A Grako; W B Stallcup
Journal:  J Biol Chem       Date:  1999-06-11       Impact factor: 5.157

5.  The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases.

Authors:  J M Whitelock; A D Murdoch; R V Iozzo; P A Underwood
Journal:  J Biol Chem       Date:  1996-04-26       Impact factor: 5.157

6.  Dynamic expression of alpha 1 beta 1 and alpha 2 beta 1 integrin receptors by human vascular smooth muscle cells. Alpha 2 beta 1 integrin is required for chemotaxis across type I collagen-coated membranes.

Authors:  M P Skinner; E W Raines; R Ross
Journal:  Am J Pathol       Date:  1994-11       Impact factor: 4.307

7.  Shedding of NG2 by MMP-13 attenuates anoikis.

Authors:  Nam E Joo; Di Miao; Mercedes Bermúdez; William B Stallcup; Yvonne L Kapila
Journal:  DNA Cell Biol       Date:  2014-12       Impact factor: 3.311

8.  NG2 proteoglycan promotes endothelial cell motility and angiogenesis via engagement of galectin-3 and alpha3beta1 integrin.

Authors:  Jun-ichi Fukushi; Irwan T Makagiansar; William B Stallcup
Journal:  Mol Biol Cell       Date:  2004-06-04       Impact factor: 4.138

9.  The progenitor cell marker NG2/MPG promotes chemoresistance by activation of integrin-dependent PI3K/Akt signaling.

Authors:  M Chekenya; C Krakstad; A Svendsen; I A Netland; V Staalesen; B B Tysnes; F Selheim; J Wang; P Ø Sakariassen; T Sandal; P E Lønning; T Flatmark; P Ø Enger; R Bjerkvig; M Sioud; W B Stallcup
Journal:  Oncogene       Date:  2008-05-12       Impact factor: 9.867

10.  The basement membrane-type heparan sulfate proteoglycan (perlecan) in ameloblastomas: its intercellular localization in stellate reticulum-like foci and biosynthesis by tumor cells in culture.

Authors:  Hiroko Ida-Yonemochi; Terué Ikarashi; Masaki Nagata; Hideyuki Hoshina; Ritsuo Takagi; Takashi Saku
Journal:  Virchows Arch       Date:  2001-11-07       Impact factor: 4.064

View more
  6 in total

1.  Monosomy 3 Influences Epithelial-Mesenchymal Transition Gene Expression in Uveal Melanoma Patients; Consequences for Liquid Biopsy.

Authors:  Andrea Soltysova; Tatiana Sedlackova; Dana Dvorska; Karin Jasek; Pooneh Chokhachi Baradaran; Viera Horvathova Kajabova; Lucia Demkova; Verona Buocikova; Terezia Kurucova; Darina Lyskova; Alena Furdova; Gabriel Minarik; Pavel Babal; Zuzana Dankova; Bozena Smolkova
Journal:  Int J Mol Sci       Date:  2020-12-17       Impact factor: 5.923

2.  Changes in the Immune Phenotype and Gene Expression Profile Driven by a Novel Tuberculosis Nanovaccine: Short and Long-Term Post-immunization.

Authors:  Amparo Martínez-Pérez; Ana Igea; Olivia Estévez; Catarina M Ferreira; Egídio Torrado; António Gil Castro; Carmen Fernández; Anna-Lena Spetz; Lucille Adam; Moisés López González; Mahavir Singh; Rajko Reljic; África González-Fernández
Journal:  Front Immunol       Date:  2021-01-28       Impact factor: 7.561

Review 3.  Utilization of glycosaminoglycans by the human gut microbiota: participating bacteria and their enzymatic machineries.

Authors:  Parkash Singh Rawat; Ahkam Saddam Seyed Hameed; Xiangfeng Meng; Weifeng Liu
Journal:  Gut Microbes       Date:  2022 Jan-Dec

4.  Achilles and tail tendons of perlecan exon 3 null heparan sulphate deficient mice display surprising improvement in tendon tensile properties and altered collagen fibril organisation compared to C57BL/6 wild type mice.

Authors:  Cindy C Shu; Margaret M Smith; Richard C Appleyard; Christopher B Little; James Melrose
Journal:  PeerJ       Date:  2018-06-29       Impact factor: 2.984

Review 5.  The Association between Genes Polymorphisms of Heparan Sulfate Proteoglycan 2 (HSPG2) and Chondroitin Sulfate Proteoglycan 2 (CSPG2) and Intracranial Aneurysm Susceptibility: A Meta-Analysis.

Authors:  Huahui Liu; Wen Huang
Journal:  Iran J Public Health       Date:  2019-11       Impact factor: 1.429

6.  A chondroitin sulfate proteoglycan 4‑specific monoclonal antibody inhibits melanoma cell invasion in a spheroid model.

Authors:  Karolina Uranowska; Mahzeiar Samadaei; Tanja Kalic; Matthias Pinter; Heimo Breiteneder; Christine Hafner
Journal:  Int J Oncol       Date:  2021-07-28       Impact factor: 5.650

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.